CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3026% above fair value
$74.56+0.84 (+1.14%)
Close on Nov 17, 2026Market cap $3.92BP/E 31.2Yield –
CareDx price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
CareDx's price to book ratio was 9.8× on Nov 11, 2026, against 3.0× a year earlier. Over the last 5 years it ranged from 0.7× to 10.6×, with a median of 2.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.8× | +6.7 |
| 2025 | Dec 31, 2025 | 3.1× | −1.0 |
| 2024 | Dec 31, 2024 | 4.2× | +2.5 |
| 2023 | Dec 29, 2023 | 1.6× | +0.3 |
| 2022 | Dec 30, 2022 | 1.4× | −3.7 |
| 2021 | Dec 31, 2021 | 5.1× | −8.2 |
| 2020 | Dec 31, 2020 | 13.3× | +3.9 |
| 2019 | Dec 31, 2019 | 9.4× | −12.6 |
| 2018 | Dec 31, 2018 | 22.0× | +11.4 |
| 2017 | Oct 31, 2017 | 10.6× | +9.0 |
| 2016 | Dec 30, 2016 | 1.6× | −0.7 |
| 2015 | Dec 31, 2015 | 2.2× | +0.2 |
| 2014 | Dec 31, 2014 | 2.1× | – |
See a number that looks wrong?